Business Context and Reporting Period
This Form 8-K filing by The Clorox Company (Clorox) reports a triggering event regarding a joint venture with The Procter & Gamble Company (P&G) concerning Clorox's Glad business. The report date is December 16, 2004, covering an event notified on December 15, 2004.
Key Financial Metrics
- Terminal Obligation Increase: $133 million.
- Total Terminal Obligation: $259 million (post-transaction).
- Cash Flow Impact: Expected increase of $133 million in the quarter of completion.
- Working Capital Impact: Expected increase of $133 million in the quarter of completion.
- Transaction Timing: Expected to close on or before January 14, 2005.
Material Changes
P&G exercised its option to increase its interest in the Glad joint venture from 10% to 20% of profits, losses, and cash flows. This action triggers an increase in Clorox's repurchase obligation (Terminal Obligation) recorded on its balance sheet. The filing does not provide comparative financial data for prior periods as this is a specific event report rather than a periodic financial statement.
Outlook, Risks, and Contingencies
The joint venture agreement has a 20-year term, extendable by 10 years. Clorox is obligated to purchase P&G's interest at fair market value upon expiration or termination. Termination rights exist for events such as the sale of Glad, a change in Clorox ownership, unresolved material disagreements, or uncured material breaches. The immediate financial impact is an increase in the recorded liability and a corresponding cash inflow upon payment.
Investor Verification Checklist
- Verify the closing date of the transaction (expected by January 14, 2005).
- Confirm the updated Terminal Obligation balance of $259 million in subsequent financial statements.
- Review the press release (Exhibit 99.1) for additional details on the Glad business performance.
- Monitor for any future amendments to the joint venture agreement or changes in the fair market value definition.